Connect with us

Technology

Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women’s Maternal Mental Healthcare with its MamaLift and MamaLift Plus Solutions

Published

on

MamaLift ensures personalized care tailored to each woman’s journey through motherhood, empowering them to manage stress, embrace joy, and reduce the risk of depression and anxiety during and after pregnancy.

SAN ANTONIO, Oct. 19, 2024 /PRNewswire/ — Frost & Sullivan assessed the women’s health digital therapeutics industry, and based on its analysis results, recognizes Curio Digital Therapeutics with the 2024 Global New Product Innovation Award. The company is a leading developer of innovative digital health solutions focused on women’s mental health. It utilizes a predictive algorithm for early identification and triage of common mental health disorders affecting women, turning data into actionable insights. Curio then offers cutting-edge digital self-guided cognitive behavioral therapy (CBT) programs integrated with live health coaches, providing on-demand care. It makes mental health support accessible to women globally, applying consistent scientific principles across different regions to address common mental and behavioral disorders. Its platform mitigates the stigma surrounding mental health issues by offering anonymity, thus empowering women to seek assistance with greater freedom and confidence.

Curio’s MamaLift is a general wellness product that manages neurobehavioral symptoms during pregnancy and postpartum period. It empowers mothers to manage stress, anxiety, and other neurobehavioral symptoms by providing bite-sized digital doses of CBT, evidence-based self management tools, insightful trackers, and on-demand access to health coaches. Curio’s “digital dose” approach uniquely ensures user-friendliness, requiring only 10 minutes of daily engagement. It caters to the busy lives of mothers, offering flexibility with audio, visual, reading and gamification options tailored to individual preferences. The platform simplifies complex mental health challenges into small, interactive, manageable tasks, facilitating easy integration into daily routines. Its feedback loop allows users to rate their experiences and provide free-text comments on each module for continuous improvement, keeping the platform responsive and user-focused. Available 24/7, it provides continuous support through adaptable self-guided modules customized to each user’s unique needs based on cultural values, nutritional habits, and personal lifestyles, ensuring personalized care throughout their motherhood journey.

Manuel Albornoz, Best Practices Research Analyst, Frost & Sullivan, observed “Curio distinguishes itself by building the largest body of evidence, with seven clinical studies published, and delivering a remarkable 5:1 return on investment. Curio’s comprehensive, AI-driven platform excels in early identification and risk stratification, significantly improving mental health outcomes for women.”

Curio’s MamaLift Plus, on the other hand, is a prescription-only digital therapeutic solution intended to provide neurobehavioral interventions to patients aged at least 22 years, as an adjunct to clinician-managed outpatient care. It treats mild to moderate postpartum depression by improving a patient’s symptoms of depression. MamaLift Plus delivers digital Cognitive Behavioral Therapy (CBT), Behavioral Activation Therapy (BAT), Interpersonal Therapy (IPT), and Dialectical Behavior Therapy (DBT) for postpartum depression. These neurobehavioral treatments focus on addressing the maladaptive behaviors, routines, and dysfunctional thoughts that perpetuate during postpartum depression. Integrating and personalizing multiple therapeutic modalities, the company provides a robust, user-centered experience, fostering better engagement and more meaningful health outcomes. With a strong focus on quality, regulatory compliance, and comprehensive reporting, Curio sets new standards in women’s healthcare, making it a market leader in digital therapeutics for mental health.

“Curio platform’s high adherence underscores its effectiveness in maintaining user engagement and delivering consistent mental health benefits. The company employs cutting-edge neurobehavioral therapy programs to address risk factors for postpartum depression. The program’s daily learning modules foster essential psychological skills such as emotion regulation, psychological flexibility, and self-compassion, providing mothers with the tools they need to navigate the challenges of motherhood,” added Supriya Lal Kundu, Industry Analyst at Frost & Sullivan.

Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased return on investment (ROI) it gives customers, which, in turn, raises customer acquisition and overall market penetration potential.

Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact us: Start the discussion.

Contact:

Ashley Shreve
E: ashley.shreve@frost.com

Photo – https://mma.prnewswire.com/media/2535250/Curio_Award.jpg

View original content:https://www.prnewswire.co.uk/news-releases/curio-digital-therapeutics-applauded-by-frost–sullivan-for-enhancing-womens-maternal-mental-healthcare-with-its-mamalift-and-mamalift-plus-solutions-302280976.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Barrel Energy Inc. Announces Full SEC Reporting Status, Strengthening Marketability and Positioning Company for Expansion in Renewable and Nutritional Energy Markets

Published

on

By

Barrel Energy Inc. (OTC: BRLL) A fully reporting company. Accelerates Growth Across Energy, Hospitality, and Sustainable Ventures, Driving Scalable Opportunities Worldwide.

LAS VEGAS, May 11, 2026 /PRNewswire/ — Barrel Energy Inc. (OTC: BRLL), an emerging diversified energy company focused on renewable energy and nutritional energy initiatives, today announced that the Company is now a fully reporting company with the U.S. Securities and Exchange Commission (“SEC”), marking a major turning point in the Company’s long term growth strategy and public market development.

Barrel Energy Inc. Announces Full SEC Reporting Status, Strengthening Marketability and positioning for Expansion.

“Our transition to becoming a fully reporting SEC company represents a significant milestone for Barrel Energy and an important step toward increasing the overall marketability and visibility of our stock,” said Jarmin Kaltsas. “We believe today’s market increasingly rewards transparency and compliance, and becoming fully reporting positions us to engage a wider audience of investors, strategic partners, and acquisition opportunities as we continue executing our long term growth strategy under the BRLL trading symbol.”

Management further stated that the Company plans to aggressively pursue growth initiatives intended to expand revenues, strengthen market presence, and enhance shareholder value through strategic business combinations, operational expansion, and scalable energy focused ventures.

About Barrel Energy Inc.

Barrel Energy Inc. (OTC: BRLL) is a diversified energy company focused on opportunities in renewable energy, and nutritional energy initiatives. The Company seeks to leverage strategic acquisitions, public market growth, and innovative energy solutions to create long term shareholder value.

Forward-Looking Statements:

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission.

Barrel Energy – 3859 S. Valley View Blvd, STE 2 #107, Las Vegas, NV, 89103 Tel- 888- 397-9114 Email- info@BRLLenergy.com Social Media-@BRLLenergy all platforms.

View original content:https://www.prnewswire.com/news-releases/barrel-energy-inc-announces-full-sec-reporting-status-strengthening-marketability-and-positioning-company-for-expansion-in-renewable-and-nutritional-energy-markets-302768505.html

SOURCE Barrel Energy, Inc.

Continue Reading

Technology

Legacy Launches $1M Study Advancing At-Home Semen Collection for Assisted Reproduction Technology

Published

on

By

NEW YORK, May 11, 2026 /PRNewswire/ — Legacy, the leading male fertility clinic and at-home sperm testing and cryopreservation platform, today announced the Sperm Study, a clinical research initiative backed by an R&D investment of over $1 million and designed to evaluate and optimize the use of at-home semen collection for assisted reproductive technologies (ART), including IVF and IUI.

Prospectively enrolling up to 250 participants across two phases, this study represents one of the most comprehensive investigations to date into how specimen shipment, handling, and cryopreservation impact sperm quality and is expected to set a new benchmark for scientific rigor in the rapidly growing field of at-home fertility testing. This study is being conducted in collaboration with IVF Academy USA.

Raising the bar for clinical evidence in at-home fertility care

To date, validation work in at-home semen collection has been limited in important ways. Studies have largely enrolled normozoospermic men only, relied on courier-transported rather than real-world-shipped specimens, and focused on short-term motility and concentration as primary endpoints.

Critical questions remain unanswered, particularly around how samples with varying quality perform under genuine end-to-end shipping conditions, and how those samples hold up in the contexts that matter most clinically: IVF and IUI. The Sperm Study is designed to close those gaps.

This multi-phase study will evaluate key sperm quality parameters including motility, DNA fragmentation, and post-thaw viability, while also validating the use of computer-aided semen analysis (CASA) as an alternative to basic manual semen analysis in the setting of mail-in semen analysis.

“With the increased utilization of at-home semen testing and cryopreservation, there is a critical need to ensure these specimens will perform adequately when used for assisted reproduction,” said Legacy’s Chief Medical Officer, Dr. Scott Lundy. “This study is designed to rigorously evaluate how at-home collection and transport impact sperm quality across a broad patient population and to translate those findings into improved protocols and optimized outcomes for both patients and providers.”

Sperm study design and scientific approach

The Sperm Study is a prospectively accruing cross-sectional study in which paired semen samples are analyzed across multiple timepoints and during the shipment process. Importantly, this study enrolls participants across a range of semen quality profiles — not solely normozoospermic men — and evaluates samples under genuine shipping conditions experienced by real specimens.

Key study components include direct comparison of CASA vs. manual analysis at baseline, evaluation of motility decline over time and in relation to shipment conditions, measurement of DNA fragmentation pre- and post-shipment and cryopreservation, assessment of post-thaw sperm viability and yield, and the development of predictive algorithms for IVF/IUI sample sufficiency.

The study will also examine how factors such as transit time, concentration, and storage conditions impact outcomes, with the goal of generating generalizable insights for clinical practice.

Multi-phase rollout

Phase 1 includes 100 participants and approximately 1,500 total assays, with expected completion in 2026. Phase 2, planned for later in 2026 and into 2027, will expand the study with additional participants, bringing the total to up to 250 to enable broader validation across a more diverse patient population.

Impact on clinical practice

Findings from the Sperm Study are expected to directly inform and improve specimen collection protocols for at-home use, shipping and handling standards for semen samples, cryopreservation practices, and clinical decision-making for IVF and IUI readiness.

By generating high-quality, controlled data across a clinically representative patient population, Legacy aims to provide fertility clinics, researchers, and patients with greater confidence in the use of mail-in semen testing and cryopreservation as part of standard reproductive care.

About Legacy

Legacy is the leading male fertility clinic in the United States, offering at-home semen analysis, sperm cryopreservation, and post-vasectomy testing. With a CLIA-certified, high-complexity andrology lab and one of the largest proprietary datasets in male reproductive health, Legacy is advancing access, data, and innovation in fertility care.

View original content to download multimedia:https://www.prnewswire.com/news-releases/legacy-launches-1m-study-advancing-at-home-semen-collection-for-assisted-reproduction-technology-302768508.html

SOURCE Give Legacy, Inc.

Continue Reading

Technology

Elks Award Nearly $5 Million in College Scholarships

Published

on

By

CHICAGO, May 11, 2026 /PRNewswire/ — The Elks National Foundation welcomed 900 students to the Elks family, awarding more than $4.9 million in scholarships to high school seniors. An Elks scholarship is more than financial aid; it’s an invitation to a network of service-minded peers and a promise that an Elks Lodge is always there with open arms.

Out of more than 23,000 applicants for the Most Valuable Student scholarship, the Top 20 scholars received $30,000 scholarships and an invitation to Chicago for the Leadership Weekend.

From April 30-May 3, the Leadership Weekend allowed scholars to get acquainted with their new Elks family through programming facilitated by current and former Elks scholars, team-building activities, and a service opportunity.

“Leadership Weekend is one of my greatest memories,” says Emily Cai, sponsored by Toccoa, Ga., Lodge No. 1820. “I had the privilege of meeting inspirational and disciplined individuals who motivated me to become the best version of myself. I am excited to see my future with the Elks family!”

A total of 480 runners-up received $4,000 Most Valuable Student scholarships.

Service is a tenet of the Elks, which is why it’s a requirement for recipients of the $6,000 Legacy Awards scholarship, which is exclusively for the children or grandchildren of Elks members. The new class of 400 scholars will serve with an Elks Lodge three times during the four years they receive the scholarship.

“This award means a great deal to me and my family,” says Kelly Butler, sponsored by Haverstraw, N.Y., Lodge No. 877. “Knowing that the Elks have invested in my future motivates me to continue working hard and striving toward my goals.”

To see a full list of the scholarship winners and to learn more about the Elks National Foundation’s scholarships, visit elks.org/scholars, follow the ENF on Instagram @ElksScholars, and like the ENF on Facebook @ElksNationalFoundation.

Contact: Elks National Foundation
Abbey Knupp | Manager, Communications
2750 N. Lakeview Ave. | Chicago, IL 60614-2256
773/755-4864 | AbbeyK@elks.org 

Helping Elks Build Stronger Communities

The Elks National Foundation, the charitable arm of the Benevolent and Protective Order of Elks, helps nearly 800,000 Elks and nearly 1,800 Lodges nationwide build stronger communities through programs that support youth, serve veterans, and meet needs in areas where Elks live and work. To learn more, visit elks.org/enf.

View original content to download multimedia:https://www.prnewswire.com/news-releases/elks-award-nearly-5-million-in-college-scholarships-302768507.html

SOURCE ELKS NATIONAL FOUNDATION, INC.

Continue Reading

Trending